A cohort of limited and extensive-stage SCLC patient biopsy samples (n = 20) (clinical characteristics summarized in Supplementary Table 4) were stained with human anti-CD31 and PAS to investigate the prevalence of VM in clinical specimens. This evidence concerns the gene PECAM1 and small cell lung carcinoma.